McCaw, Z. R., Tian, L., Kim, D. H., & Wei, L. (2019). Comment on “Interpreting Clinical Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer (BRPC)”. Ann Surg.
Παραπομπή Chicago StyleMcCaw, Zachary R., Lu Tian, Dae Hyun Kim, και Lee-Jen Wei. "Comment On “Interpreting Clinical Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer (BRPC)”." Ann Surg 2019.
Παραπομπή MLAMcCaw, Zachary R., Lu Tian, Dae Hyun Kim, και Lee-Jen Wei. "Comment On “Interpreting Clinical Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer (BRPC)”." Ann Surg 2019.